• Predisposing Factors: Solar exposure, chemical carcinogens, ionizing radiation, and genetic/hormonal/viral factors.
Undifferentiated & Anaplastic Sarcomas
• Nature: These are malignant mesenchymal tumors.
• Microscopic Characteristics:
◦ Undifferentiated Sarcomas: They are difficult to characterize microscopically because they lack distinctive features such as architectural patterns, cell products, or specific cytoplasmic/nuclear features,.
◦ Anaplastic Sarcomas: These are generally undifferentiated but possess specific cellular irregularities: variations in nuclear size/shape, nuclear hyperchromasia, irregular chromatin patterns, and large numbers of abnormal mitotic figures.
• Diagnosis: Often require immunohistochemistry to detect cellular markers and determine the phenotype.
• Prognosis: The prognosis is generally poorer for anaplastic sarcomas than for undifferentiated sarcomas.
Lymphocytic, Mast Cell & Histiocytic Tumors
• Mast Cell Tumors (MCT): Most common malignant skin tumor in dogs; behavior is highly variable and graded via histopathology.
• Lymphocytic:
◦ Plasmacytomas: Usually benign nodules on the head/ears of dogs.
◦ Lymphosarcoma: Can be epitheliotropic (T-cell, patch/plaque/tumor progression) or nonepitheliotropic (aggressive, systemic).
• Histiocytic: Includes "button tumors" (benign, often regress) and aggressive systemic/malignant histiocytosis (common in Bernese Mountain Dogs).
Epidermal, Glandular & Hair Follicle Tumors:
• Basal Cell: Benign tumors vs. malignant carcinomas (locally invasive).
• Squamous Cell Carcinoma (SCC): Solar-induced; subungual forms can invade bone and metastasize.
• Hair Follicle: Trichoepitheliomas and Pilomatricomas (malignant forms can metastasize to lungs).
• Cytology (FNA): Essential for initial screening and treatment planning.
• Histopathology: Required for definitive diagnosis, grading, and margin assessment.
• Phenotyping: Crucial for undifferentiated/anaplastic sarcomas via immunohistochemistry.
Treatment & Management
• Surgical Excision:
◦ General: Primary treatment for most skin tumors.
◦ Wide Margins: For malignant tumors, including undifferentiated and anaplastic sarcomas, excision should be deep and wide with 3-cm margins.
◦ Importance of First Surgery: For sarcomas, the first surgery combined with immediate follow-up is the most important factor in determining the outcome.
• Multi-modal Therapy:
◦ Sarcomas: Often require a combination of intraoperative and follow-up oncologic techniques.
◦ Other: Radiation, systemic/intralesional chemotherapy, and tyrosine-kinase inhibitors (for MCT).
• Follow-up: Long-term monitoring (at least 2 years) is recommended to check for local recurrence.